logo

For the Inventor, By the Inventor

St. Louis, MO, United States of America

Shashidhar N Rao

This inventor holds 19 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: G.d. Searle & Company, Pharmacia Corporation, G.d. Searle LLC. Active years: 1995-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shashidhar N Rao. Retrieved from https://idiyas.com/inventor/shashidhar-n-rao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19

% Patents Active = 42.1

Average Co-Inventor Count = 10.3

ph-index = 7

Forward Citations = 231(Granted Patents)


Location History:

  • Mundelein, IL (US) (1995 - 2004)
  • Saint Louis, MO (US) (2004)
  • St. Louis, MO (US) (2002 - 2006)
  • Plainsboro, NJ (US) (2006)

Company Filing History:

goldMedal10 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal6 out of 220 
 
Pharmacia Corporation
 patents
bronzeMedal2 out of 33 
 
G.d. Searle LLC
 patents
4. 1 out of 2,538 
 
Warner-Lambert Company
 patents

Years Active: 1995-2006

Loading Chart...
Areas of Expertise:
p38 Kinase Inhibitors
Metalloprotease Inhibitors
Sulfamato Hydroxamic Acid
Sulfonyl Aryl Compounds
Heterocyclic Derivatives
Dibenzoxazepine Compounds
Hydroxamic Acid Compounds
Cyclopropyl Alkanoic Acid
19 patents (USPTO):Explore Patents
1. 7153959 - Substituted pyrazoles as p38 kinase inhibitors (2006-12-26),
2. 7071198 - Substituted pyrazoles as p38 kinase inhibitors (2006-07-04),
3. 7067670 - Sulfamato hydroxamic acid metalloprotease inhibitor (2006-06-27),
4. 6979686 - Substituted pyrazoles as p38 kinase inhibitors (2005-12-27),
5. 6800646 - Sulfamato hydroxamic acid metalloprotease inhibitor (2004-10-05),
6. 6794511 - Sulfonyl aryl or heteroaryl hydroxamic acid compounds (2004-09-21),
7. 6696449 - Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors (2004-02-24),
8. 6689754 - Heterocyclic glycyl &bgr;-alanine derivatives (2004-02-10),
9. 6656954 - Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds (2003-12-02),
10. 6617324 - Substituted pyrazoles as p38 kinase inhibitors (2003-09-09),
11. 6525059 - Substituted pyrazoles as p38 kinase inhibitors (2003-02-25),
12. 6514977 - Substituted pyrazoles as p38 kinase inhibitors (2003-02-04),
13. 6492367 - Sulfamato hydroxamic acid metalloprotease inhibitor (2002-12-10),
14. 6448250 - Sulfamato hydroxamic acid metalloprotease inhibitor (2002-09-10),
15. 6423713 - Substituted pyrazoles as p38 kinase inhibitors (2002-07-23),

Title: The Innovative Journey of Inventor Shashidhar N Rao

Introduction:

In the realm of innovation, one name that shines brightly is Shashidhar N Rao, a prolific inventor based in St. Louis, Missouri. With an impressive portfolio of 19 patents, his work has significantly contributed to the field of pharmaceuticals and p38 kinase inhibitors.

Latest Patents:

Shashidhar N Rao's latest patents revolve around "Substituted pyrazoles as p38 kinase inhibitors" - a groundbreaking class of pyrazole derivatives designed for treating p38 kinase-mediated disorders. These compounds, defined by Formula IA, showcase his dedication to advancing medical treatment options.

Career Highlights:

Throughout his career, Shashidhar N Rao has made notable contributions at reputable companies such as G.D. Searle & Company and Pharmacia Corporation. His innovative mindset and expertise have led to pioneering developments in the pharmaceutical industry, earning him recognition as a thought leader in his field.

Collaborations:

Collaboration is key in the world of invention, and Shashidhar N Rao has had the privilege of working alongside esteemed colleagues like Gary A DeCrescenzo and Michael John Clare. Together, they have shared insights, ideas, and expertise, fostering a culture of innovation and excellence.

Conclusion:

In conclusion, Shashidhar N Rao's journey as an inventor is nothing short of remarkable. With a passion for pushing boundaries and improving human health, he continues to inspire others in the field of pharmaceutical research. His inventive spirit and dedication to advancing scientific knowledge make him a true pioneer in the world of innovations and patents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…